/Investor DB

The Engine Ventures — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Forayforaybio.cominFeb 2024

Foray Bioscience uses single plant cells and AI-powered software (Pando) to direct how plant matter forms, producing plant materials, molecules, and seeds without growing whole plants.

AgTechAI & Machine LearningBiotechCambridge, US

Ashley Beckwith(Founder & CEO)in

Co-investorsCollaborative FundService Provider CapitalReGen VenturesTet Ventures

Kano Therapeuticskanotherapeutics.comin𝕏May 2024

Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.

BiotechDeep TechCambridge, US

Floris Engelhardt(Executive Officer, Director)John Vroom(Director)

BoardAnn DeWitt(Director)in

Co-investorsFifty YearsLaunchpad Venture GroupMetaplanetVsquared VenturesZAKA VC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.